Bright Minds Biosciences Inc. (DRUG)
NASDAQ: DRUG · Real-Time Price · USD
79.33
-1.47 (-1.82%)
At close: Aug 7, 2026, 4:00 PM EDT
78.64
-0.69 (-0.87%)
After-hours: Aug 7, 2026, 7:34 PM EDT
Bright Minds Biosciences Market Cap
Bright Minds Biosciences has a market cap or net worth of $781.58 million as of August 7, 2026. Its market cap has increased by 240.71% in one year.
Market Cap
781.58M
Enterprise Value
559.44M
1-Year Change
240.71%
Ranking
Category
Stock Price
$79.33
ChartMarket Cap Chart
Since February 8, 2021, Bright Minds Biosciences's market cap has increased from $41.78M to $781.58M, an increase of 1,770.56%. That is a compound annual growth rate of 70.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 781.58M | 24.62% |
| Dec 31, 2025 | 627.18M | 150.23% |
| Dec 31, 2024 | 250.64M | 3,397.75% |
| Dec 29, 2023 | 7.17M | -49.18% |
| Dec 30, 2022 | 14.10M | -63.08% |
| Dec 31, 2021 | 38.19M | -8.59% |
| Feb 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SpyGlass Pharma | 846.57M |
| Climb Bio | 804.11M |
| Monopar Therapeutics | 798.56M |
| DBV Technologies | 795.72M |
| Pharming Group | 785.51M |
| Candel Therapeutics | 775.93M |
| Tenax Therapeutics | 769.87M |
| Oculis Holding AG | 765.72M |